Condition
Cluster Headache, Episodic
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04688775Phase 3CompletedPrimary
Eptinezumab in Participants With Episodic Cluster Headache
NCT04014634Phase 4CompletedPrimary
GON-injection for a Sooner and Better Treatment of Cluster Headache
NCT05084469UnknownPrimary
Exploration of Cluster Headache in a PET-MRI Study
Showing all 3 trials